ArticleThe plant genome2026
Optimum recombination rates for genetic gains in simulated recurrent selection in empirical maize populations.
Article in The plant genome, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Optimum recombination rates for genetic gains in simulated recurrent selection in empirical maize populations.The plant genome · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Meiotic recombination creates new allelic combinations, but it also disrupts favorable parental haplotypes. Our objective was to assess if optimum recombination rates exist in elite maize (Zea mays L.) populations undergoing simulated short-term and long-term recurrent selection. Genomewide marker effects were calculated for eight populations genotyped with 3072 single nucleotide polymorphism markers and phenotyped in up to 18 environments for yield, moisture, test weight, and plant and ear height. The recombination rate was altered by multiplying the sizes of linkage maps by 0.25-10. The regression of genetic gain on the number of crossovers was often curvilinear, and an optimum number of crossovers (CO
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.